Full Text View
Tabular View
No Study Results Posted
Related Studies
Hydralazine as a Demethylating Agent in Rectal Cancer
This study has been withdrawn prior to enrollment.
( No enrollment )
Study NCT00575640   Information provided by University of Arkansas

First Received on December 14, 2007.   Last Updated on December 3, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Rectal Cancer
Additional conditions recognized in this trial
Rectal Neoplasms
More general conditions related to this trial
Colorectal Neoplasms
Digestive System Diseases
Digestive System Neoplasms
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Intestinal Diseases
Intestinal Neoplasms
Neoplasms
Neoplasms by Site
Rectal Diseases
Interventions listed in this trial
Hydralazine
More general drug interventions related to this trial
Antihypertensive Agents
Cardiovascular Agents
Pharmacologic Actions
Therapeutic Uses
Vasodilator Agents
Sponsors listed in this trial
University of Arkansas


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services